Calcium signal-mediated activation of NLRP3 inflammasome

CHEN Yu; XU Zhimeng; LI Ping

doi:10.11665/j.issn.1000-5048.20210501

Journal of China Pharmaceutical University > 2021 > 52(5): 513-521. > DOI: 10.11665/j.issn.1000-5048.20210501

CHEN Yu, XU Zhimeng, LI Ping. Calcium signal-mediated activation of NLRP3 inflammasome[J]. Journal of China Pharmaceutical University, 2021, 52(5): 513-521. DOI: 10.11665/j.issn.1000-5048.20210501

Citation:

CHEN Yu, XU Zhimeng, LI Ping. Calcium signal-mediated activation of NLRP3 inflammasome[J]. Journal of China Pharmaceutical University, 2021, 52(5): 513-521. DOI: 10.11665/j.issn.1000-5048.20210501

Citation:

CHEN Yu, XU Zhimeng, LI Ping. Calcium signal-mediated activation of NLRP3 inflammasome[J]. Journal of China Pharmaceutical University, 2021, 52(5): 513-521. DOI: 10.11665/j.issn.1000-5048.20210501

PDF (2156 KB)

Calcium signal-mediated activation of NLRP3 inflammasome

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China

Funds: This study was supported by the National Key Research and Development Program of China (No.2018YFC1707300)

More Information

Received Date: March 09, 2021
Revised Date: September 06, 2021

Graphical Abstract

Abstract

Abstract

Nod-like receptor protein 3 (NLRP3) inflammasome, which is an important component of the innate immune system, can recognize a variety of pathogens and cell damage, induce the secretion of IL-1β and IL-18, and regulate imflammatory response.More and more studies in recent years have shown that Ca²⁺ signaling plays an important role in NLRP3 inflammasome activation induced by various NLRP3 inflammasome agonists, and is closely related to the occurrence of related diseases.The article reviews the literatures on Ca²⁺ and NLRP3 inflammasome, focusing on the potential role of Ca²⁺ signaling in the activation and regulation of NLRP3 inflammasome, to provide new ideas for the treatment of illness caused by NLRP3 inflammasome.
- NLRP3 inflammasome,
- calcium signaling,
- activation mechanism

FullText(HTML)

References (63)

References

[1]	. Nat Rev Immunol，2019，19（3）： 154-169.
[2]	Murakami T，Ockinger J，Yu J，et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome［J］. PNAS，2012，109（28）： 11282-11287.
[3]	He Y，Zeng MY，Yang D，et al. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux［J］. Nature，2016，530（7590）： 354-357.
[4]	Kuri P，Schieber NL，Thumberger T，et al. Dynamics of in vivo ASC speck formation［J］. J Cell Biol，2017，216（9）： 2891-2909.
[5]	Dick MS，Sborgi L，Rühl S，et al. ASC filament formation serves as a signal amplification mechanism for inflammasomes［J］. Nat Commun，2016，7： 11929.
[6]	Hoss F，Rodriguez-Alcazar JF，Latz E. Assembly and regulation of ASC specks［J］. Cell Mol Life Sci，2017，74（7）： 1211-1229.
[7]	Broz P，Dixit VM. Inflammasomes： mechanism of assembly，regulation and signalling［J］. Nat Rev Immunol，2016，16（7）： 407-420.
[8]	Barnett KC，Ting JP. Mitochondrial GSDMD pores DAMPen pyroptosis［J］. Immunity，2020，52（3）： 424-426.
[9]	Swanson KV，Deng M，Ting JP. The NLRP3 inflammasome： molecular activation and regulation to therapeutics［J］. Nat Rev Immunol，2019，19（8）： 477-489.
[10]	Wu JS，Sun JY，Meng XL. Pyroptosis by caspase-11 inflammasome-Gasdermin D pathway in autoimmune diseases［J］. Pharmacol Res，2021，165： 105408.
[11]	Bauernfeind F，Bartok E，Rieger A，et al. Cutting edge： reactive oxygen species inhibitors block priming，but not activation，of the NLRP3 inflammasome［J］. J Immunol，2011，187（2）： 613-617.
[12]	Mu?oz-Planillo R，Kuffa P，Martínez-Colón G，et al. K? efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter［J］. Immunity，2013，38（6）： 1142-1153.
[13]	Zhang YF，Rong H，Zhang FX，et al. A membrane potential- and calpain-dependent reversal of caspase-1 inhibition regulates canonical NLRP3 inflammasome［J］. Cell Rep，2018，24（9）： 2356-2369.
[14]	Gro? CJ，Mishra R，Schneider KS，et al. K⁺ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria［J］. Immunity，2016，45（4）： 761-773.
[15]	Orlowski GM，Sharma S，Colbert JD，et al. Frontline Science： multiple cathepsins promote inflammasome-independent，particle-induced cell death during NLRP3-dependent IL-1β activation［J］. J Leukoc Biol，2017，102（1）： 7-17.
[16]	Chen JQ，Chen ZJ. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation［J］. Nature，2018，564（7734）： 71-76.
[17]	Calvo-Rodriguez M，Kharitonova EK，Bacskai BJ. Therapeutic strategies to target calcium dysregulation in Alzheimer''s disease［J］. Cells，2020，9（11）： E2513.
[18]	Park YJ，Yoo SA，Kim M，et al. The role of calcium-calcineurin-NFAT signaling pathway in health and autoimmune diseases［J］. Front Immunol，2020，11： 195.
[19]	Michelucci A，García-Casta?eda M，Boncompagni S，et al. Role of STIM1/ORAI1-mediated store-operated Ca²⁺ entry in skeletal muscle physiology and disease［J］. Cell Calcium，2018，76： 101-115.
[20]	Chu J，Thomas LM，Watkins SC，et al. Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner［J］. J Leukoc Biol，2009，86（5）： 1227-1238.
[21]	Xi YH，Li HZ，Zhang WH，et al. The functional expression of calcium-sensing receptor in the differentiated THP-1 cells［J］. Mol Cell Biochem，2010，342（1/2）： 233-240.
[22]	Lee GS，Subramanian N，Kim AI，et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca²⁺ and cAMP［J］. Nature，2012，492（7427）： 123-127.
[23]	Ito M，Yanagi Y，Ichinohe T. Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome［J］. PLoS Pathog，2012，8（8）： e1002857.
[24]	Shrivastava G，Visoso-Carvajal G，Garcia-Cordero J，et al. Dengue virus serotype 2 and its non-structural proteins 2A and 2B activate NLRP3 inflammasome［J］. Front Immunol，2020，11： 352.
[25]	Karmakar M，Katsnelson MA，Dubyak GR，et al. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP［J］. Nat Commun，2016，7： 10555.
[26]	Ahmad I，Muneer KM，Chang ME，et al. Ultraviolet radiation-induced downregulation of SERCA2 mediates activation of NLRP3 inflammasome in basal cell carcinoma［J］. Photochem Photobiol，2017，93（4）： 1025-1033.
[27]	Gong T，Wang XQ，Yang YQ，et al. Plant lectins activate the NLRP3 inflammasome to promote inflammatory disorders［J］. J Immunol，2017，198（5）： 2082-2092.
[28]	Katsnelson MA，Rucker LG，Russo HM，et al. K⁺ efflux agonists induce NLRP3 inflammasome activation independently of Ca²⁺ signaling［J］. J Immunol，2015，194（8）： 3937-3952.
[29]	Katsnelson MA，Lozada-Soto KM，Russo HM，et al. NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption： roles for K⁺ efflux and Ca²⁺ influx［J］. Am J Physiol Cell Physiol，2016，311（1）： C83-C100.
[30]	Zumerle S，Calì B，Munari F，et al. Intercellular calcium signaling induced by ATP potentiates macrophage phagocytosis［J］. Cell Rep，2019，27（1）： 1-10.
[31]	Zhang CF，Qin JL，Zhang S，et al. ADP/P2Y₁ aggravates inflammatory bowel disease through ERK5-mediated NLRP3 inflammasome activation［J］. Mucosal Immunol，2020，13（6）： 931-945.
[32]	J?ger E，Murthy S，Schmidt C，et al. Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis［J］. Nat Commun，2020，11（1）： 4243.
[33]	Tauseef M，Knezevic N，Chava KR，et al. TLR4 activation of TRPC₆-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation［J］. J Exp Med，2012，209（11）： 1953-1968.
[34]	Zhong ZY，Zhai YG，Liang S，et al. TR/MIN2 links oxidative stress to NLRP3 inflammasome activation［J］. Nat Commun，2013，4（1）： 1-11.
[35]	Wang MY，Zhang YB，Xu MM，et al. Roles of TRPA1 and TRPV₁ in cigarette smoke -induced airway epithelial cell injury model［J］. Free Radic Biol Med，2019，134： 229-238.
[36]	Compan V，Baroja-Mazo A，López-Castejón G，et al. Cell volume regulation modulates NLRP3 inflammasome activation［J］. Immunity，2012，37（3）： 487-500.
[37]	Liu CC，Miao Y，Chen RL，et al. STIM1 mediates IAV-induced inflammation of lung epithelial cells by regulating NLRP3 and inflammasome activation via targeting miR-223［J］. Life Sci，2021，266： 118845.
[38]	Murayama T，Kurebayashi N. Assays for modulators of ryanodine receptor （RyR）/Ca²⁺ release channel activity for drug discovery for skeletal muscle and heart diseases［J］. Curr Protoc Pharmacol，2019，87（1）： e71.
[39]	Morgan AJ，Yuan Y，Patel S，et al. Does lysosomal rupture evoke Ca²⁺ release？ A question of pores and stores［J］. Cell Calcium，2020，86： 102139.
[40]	Okada M，Matsuzawa A，Yoshimura A，et al. The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation［J］. J Biol Chem，2014，289（47）： 32926-32936.
[41]	Xu MD，Jiang ZY，Wang CL，et al. Publisher correction： acetate attenuates inflammasome activation through GPR43-mediated Ca²⁺-dependent NLRP3 ubiquitination［J］. Exp Mol Med，2019，51（8）： 1.
[42]	Lim JR，Lee HJ，Jung YH，et al. Ethanol-activated CaMKII signaling induces neuronal apoptosis through Drp1-mediated excessive mitochondrial fission and JNK₁-dependent NLRP3 inflammasome activation［J］. Cell Commun Signal，2020，18（1）： 123.
[43]	Chen H，Yang DH，Han FJ，et al. The bacterial T6SS effector EvpP prevents NLRP3 inflammasome activation by inhibiting the Ca²⁺-dependent MAPK-JNK pathway［J］. Cell Host Microbe，2017，21（1）： 47-58.
[44]	Nozawa T，Sano S，Minowa-Nozawa A，et al. TBC1D9 regulates TBK₁ activation through Ca²⁺ signaling in selective autophagy［J］. Nat Commun，2020，11（1）： 770.
[45]	Han XJ，Sun SF，Sun YM，et al. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy： implications for Parkinson disease［J］. Autophagy，2019，15（11）： 1860-1881.
[46]	Zhong ZY，Liang S，Sanchez-Lopez E，et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation［J］. Nature，2018，560（7717）： 198-203.
[47]	Li W，Cao T，Luo CY，et al. Crosstalk between ER stress，NLRP3 inflammasome，and inflammation［J］. Appl Microbiol Biotechnol，2020，104（14）： 6129-6140.
[48]	Misawa T，Takahama M，Kozaki T，et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome［J］. Nat Immunol，2013，14（5）： 454-460.
[49]	Li JP，Wei W，Li XX，et al. Regulation of NLRP3 inflammasome by CD38 through cADPR-mediated Ca²⁺ release in vascular smooth muscle cells in diabetic mice［J］. Life Sci，2020，255： 117758.
[50]	Rimessi A，Bezzerri V，Patergnani S，et al. Mitochondrial Ca²⁺-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis［J］. Nat Commun，2015，6： 6201.
[51]	Rimessi A，Pozzato C，Carparelli L，et al. Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis［J］. Sci Adv，2020，6（19）： eaax9093.
[52]	Ichinohe T，Yamazaki T，Koshiba T，et al. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection［J］. PNAS，2013，110（44）： 17963-17968.
[53]	Zhang XW，Wang RH，Hu D，et al. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer''s disease［J］. Sci Adv，2020，6（49）： eabb8680.
[54]	Yin NN，Gao QH，Tao WT，et al. Paeoniflorin relieves LPS-induced inflammatory pain in mice by inhibiting NLRP3 inflammasome activation via transient receptor potential vanilloid 1［J］. J Leukoc Biol，2020，108（1）： 229-241.
[55]	Inzucchi SE，Fitchett D，Juri?i?-Er?en D，et al. Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy［J］？Diabetes Obes Metab，2020，22（4）： 631-639.
[56]	Zhou ZE，Jardine MJ，Li Q，et al. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease： results from the CREDENCE trial and meta-analysis［J］. Stroke，2021，52（5）： 1545-1556.
[57]	Byrne NJ，Matsumura N，Maayah ZH，et al. Empagliflozin blunts worsening cardiac dysfunction associated with reduced NLRP3 （nucleotide-binding domain-like receptor protein 3） inflammasome activation in heart failure［J］. Circ Heart Fail，2020，13（1）： e006277.
[58]	White JP，Cibelli M，Urban L，et al. TRPV4： molecular conductor of a diverse orchestra［J］. Physiol Rev，2016，96（3）： 911-973.
[59]	Wang Z，Zhou L，An D，et al. TRPV₄-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice［J］. Cell Death Dis，2019，10（6）： 386.
[60]	Elrashidy RA，Hasan RA. Modulation of autophagy and transient receptor potential vanilloid 4 channels by montelukast in a rat model of hemorrhagic cystitis［J］. Life Sci，2021，278： 119507.
[61]	Vincent F，Duncton MA. TRPV₄ agonists and antagonists［J］. Curr Top Med Chem，2011，11（17）： 2216-2226.
[62]	Lawhorn BG，Brnardic EJ，Behm DJ. TRPV₄ antagonists：a patent review （2015-2020）［J］. Expert Opin Ther Pat，2021，31（9）： 773-784.
[63]	Goyal N，Skrdla P，Schroyer R，et al. Clinical pharmacokinetics，safety，and tolerability of a novel，first-in-class TRPV₄ ion channel inhibitor，GSK2798745，in healthy and heart failure subjects［J］. Am J Cardiovasc Drugs，2019，19（3）： 335-342.

[1]	QIAN Xiuhui, SUN Jing, FU San, TANG Xiaoyan, XU Xianghong, ZHANG Mian. Effect of intratracheal instillation of PM_2.5suspensionon pulmonary fibrosis in mice and the intervention of neotuberostemonine[J]. Journal of China Pharmaceutical University, 2021, 52(4): 455-462. DOI: 10.11665/j.issn.1000-5048.20210408
[2]	FANG Daqing, LIU Fang, ZHANG Sijia, CAI Chaoqun, LIU Minzhuo, LIU Jinghan, YANG Chunhua, WANG Hao. One new diterpenoid alkaloid from Aconitum carmichaeli[J]. Journal of China Pharmaceutical University, 2017, 48(5): 568-571. DOI: 10.11665/j.issn.1000-5048.20170510
[3]	XIANG Juan, YU Ping, LI Mingdan, ZHANG Chaofeng, XU Xianghong, ZHANG Mian. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2017, 48(1): 76-81. DOI: 10.11665/j.issn.1000-5048.20170112
[4]	YAO Juan, XIONG Fei, ZHU Zi-yi, LIU Jian-ping, GU Ning. Preparation and in vitro evaluation of vincristine-loaded superparamagnetic iron oxide nanoparticles[J]. Journal of China Pharmaceutical University, 2012, 43(3): 222-225.
[5]	Comparative pharmacokinetics of aconitine, mesaconitine and hypaconitine in rats after oral administration of four decoctions composed with Radix Aconiti Lateralis[J]. Journal of China Pharmaceutical University, 2010, 41(1): 55-59.
[10]	POLLEN MORPHOLOGY IN CHINESE SPECIES OF STEMONA[J]. Journal of China Pharmaceutical University, 1989, (6): 325-329.

Cited By

Get Citation

PDF

XML

Article views (733) PDF downloads (951)

Turn off MathJax

Article Contents

Abstract

References

Calcium signal-mediated activation of NLRP3 inflammasome

Abstract

References

Related Articles

Catalog

Calcium signal-mediated activation of NLRP3 inflammasome

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content